ACETAMINOPHEN; PENTAZOCINE HYDROCHLORIDE | A074699 | WATSON LABORATORIES
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Xspire Pharma, LLC - Citizen Petition FDA-2012-P-0478 · 3 docket documents Xspire Pharma, LLC filed this ANDA Suitability Petition under 21 CFR 314.93 on May 7, 2012, requesting permission to submit an Abbreviated New Drug Application for Acetaminophen and Pentazocine Hydrochloride Tablets reformulated to a strength of 312.5 mg acetaminophen and 25 mg pentazocine hydrochlo | Other | 2012-05-14 | Open | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.